-
Letter from Leading Cancer-Related Provider Groups and Patient Advocates on Genetic Testing for Oncology
-
Understanding the Role of Clinical Laboratories in Supporting Substance Abuse Recovery
September 7, 2023 update: Based on discussions with ACLA and other key stakeholders, CMS has made the decision to withdraw the policy change referenced in the ... Read More -
ACLA Submits Comments on CMS Transitional Coverage For Emerging Technologies Notice
-
ACLA Submits Comments on CMS Pre-Exposure Prophylaxis (PrEP) Proposed NCD
-
ACLA Submits Comments on the CDC’s NCVHS ICD-11 RFI
-
ACLA Submits Comments on Palmetto Special Stains/IHC Proposed LCD
-
Letter to ONDCP on NCCI Edits for Drug Testing
-
ACLA Submits Comments on Senate HELP Committee RFI on Reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA)
-
Letter from Leading Patient Advocacy Organizations on Passing the Saving Access to Laboratory Services Act
-
Routine Health Checkups – Including Recommended Laboratory Tests – Improve and Save Men’s Lives
June is Men’s Health Month, an opportunity to focus on the many ways that recommended clinical laboratory testing is essential in assessing, addressing and managing ... Read More
